Daniel P. Bondeson
Broad Institute(US)Broad Institute(US)University of Massachusetts Chan Medical School(US)UMass Memorial Medical Center(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Ubiquitin and proteasome pathways, Multiple Myeloma Research and Treatments, CAR-T cell therapy research
Most-Cited Works
- → Catalytic in vivo protein knockdown by small-molecule PROTACs(2015)1,271 cited
- → Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead(2017)876 cited
- → The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study(2017)650 cited
- → Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation(2019)217 cited
- → Targeted Protein Degradation by Small Molecules(2016)199 cited
- → Phosphate dysregulation via the XPR1–KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer(2022)76 cited